Petros Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Petros Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
  • Petros Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.28M, a 7.39% increase year-over-year.
  • Petros Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$16.1M, a 25.5% increase year-over-year.
  • Petros Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$13.6M, a 31.6% increase from 2022.
  • Petros Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$19.9M, a 10.3% decline from 2021.
  • Petros Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$18M, a 4.43% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$16.1M -$2.28M +$182K +7.39% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$16.2M -$3.93M -$2.62M -200% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$13.6M -$5.04M -$938K -22.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$12.7M -$4.81M +$8.87M +64.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-15
Q2 2023 -$21.5M -$2.46M -$801K -48.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$20.7M -$1.31M -$828K -172% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$19.9M -$4.1M +$3.87M +48.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$23.8M -$13.7M -$10.1M -280% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 -$13.7M -$1.66M +$2.62M +61.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$16.3M -$481K +$1.72M +78.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$18M -$7.97M -$3.66M -84.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$14.4M -$3.6M -$1.26M -53.9% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-15
Q2 2021 -$13.1M -$4.28M +$738K +14.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$13.9M -$2.2M +$3.41M +60.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$17.3M -$4.32M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$2.34M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$5.02M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$5.61M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.